首页 > 最新文献

The Lancet. Child & adolescent health最新文献

英文 中文
Tuberculosis research principles and priorities in children and adolescents: an international consensus statement 儿童和青少年结核病研究原则和重点:一项国际共识声明
Pub Date : 2026-03-23 DOI: 10.1016/s2352-4642(26)00046-5
Moorine P Sekadde, Silvia S Chiang, Annemieke Brands, Martina Casenghi, Chishala Chabala, Stephen M Graham, Tiziana Masini, James A Seddon, Sabine E Verkuijl, Kerri Viney, Ben J Marais, Shakil Ahmed, Pauline M. Amuge, Robindra Basu Roy, Maryline Bonnet, Grania Brigden, Charlotte Colvin, Claudia M. Denkinger, Peter J. Dodd, Leslie A. Enane, Molly F. Franke, Jennifer J. Furin, Betina Mendez Alcântra Gabardo, Anthony J. Garcia-Prats, Norma E. González, Graeme Hoddinott, Cleotilde H. How, Helena Huerga, Julie Huynh, Devan Jaganath, Alexander W. Kay, Kobto G. Koura, Katharina Kranzer, Marian Loveday, Elizabeth Maleche-Obimbo, Mariama Mahmoud, Olivier Marcy, Mansa Mbenga, Lindsay R. McKenna, Brittany K. Moore, Sharon Nachman, Nicole Salazar-Austin, Clemax C. Sant'Anna, Adong Shen, H. Simon Schaaf, Sangeeta Sharma, Alena Skrahina, Jeffrey R. Starke, Marc Tebruegge, Rina Triasih, Marieke M. van der Zalm, Courtney M. Yuen, Heather J. Zar
{"title":"Tuberculosis research principles and priorities in children and adolescents: an international consensus statement","authors":"Moorine P Sekadde, Silvia S Chiang, Annemieke Brands, Martina Casenghi, Chishala Chabala, Stephen M Graham, Tiziana Masini, James A Seddon, Sabine E Verkuijl, Kerri Viney, Ben J Marais, Shakil Ahmed, Pauline M. Amuge, Robindra Basu Roy, Maryline Bonnet, Grania Brigden, Charlotte Colvin, Claudia M. Denkinger, Peter J. Dodd, Leslie A. Enane, Molly F. Franke, Jennifer J. Furin, Betina Mendez Alcântra Gabardo, Anthony J. Garcia-Prats, Norma E. González, Graeme Hoddinott, Cleotilde H. How, Helena Huerga, Julie Huynh, Devan Jaganath, Alexander W. Kay, Kobto G. Koura, Katharina Kranzer, Marian Loveday, Elizabeth Maleche-Obimbo, Mariama Mahmoud, Olivier Marcy, Mansa Mbenga, Lindsay R. McKenna, Brittany K. Moore, Sharon Nachman, Nicole Salazar-Austin, Clemax C. Sant'Anna, Adong Shen, H. Simon Schaaf, Sangeeta Sharma, Alena Skrahina, Jeffrey R. Starke, Marc Tebruegge, Rina Triasih, Marieke M. van der Zalm, Courtney M. Yuen, Heather J. Zar","doi":"10.1016/s2352-4642(26)00046-5","DOIUrl":"https://doi.org/10.1016/s2352-4642(26)00046-5","url":null,"abstract":"","PeriodicalId":94246,"journal":{"name":"The Lancet. Child & adolescent health","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147502055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paediatric TB: celebrating the people behind the progress 儿科结核病:为取得进展的人庆祝
Pub Date : 2026-03-23 DOI: 10.1016/s2352-4642(26)00071-4
{"title":"Paediatric TB: celebrating the people behind the progress","authors":"","doi":"10.1016/s2352-4642(26)00071-4","DOIUrl":"https://doi.org/10.1016/s2352-4642(26)00071-4","url":null,"abstract":"","PeriodicalId":94246,"journal":{"name":"The Lancet. Child & adolescent health","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147502054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial 霉酚酸酯与泼尼松用于德国儿童特发性类固醇敏感肾病综合征的初始治疗(INTENT):一项多中心、开放标签、随机、对照、平行组、非劣效性的3期试验
Pub Date : 2026-03-16 DOI: 10.1016/s2352-4642(25)00373-6
Marcus R Benz MD, Anja Sander PhD, Rasmus Ehren MD, Prof Britta Höcker MD, Alexander Fichtner MD, Jutta Gellermann MD, Julia Thumfart MD, Brigitte Mayer MD, Katja Sauerstein MD, Anne Mühlig PhD, Raphael Schild MD, Nele Kanzelmeyer MD, Prof Dieter Haffner MD, Henry Fehrenbach MD, Prof Martin Pohl MD, Prof Günter Klaus MD, Silke C Schmidt MD, Prof Martin Konrad MD, Prof Uwe Querfeld MD, Prof Peter F Hoyer MD, Prof Jörg Dötsch MD, Prof Markus J Kemper MD, Alexandra Balzer MSc, Jan Meis PhD, Prof Burkhard Tönshoff MD, Prof Lutz T Weber MD, INTENT investigators, Marcus R. Benz, Anja Sander, Rasmus Ehren, Britta Höcker, Alexander Fichtner, Jutta Gellermann, Julia Thumfart, Norbert Jorch, Brigitte Mayer, Maria Heyde, Matthias Galiano, Katja Sauerstein, Ludwig Patzer, Jun Oh, Anne Mühlig, Raphael Schild, Nele Kanzelmeyer, Dieter Haffner, Henry Fehrenbach, Felix Lechner, Bärbel Lange-Sperandio, Michael van Husen, Martin Pohl, Karsten Häffner, Katalin Dittrich, Stefanie Weber, Günter Klaus, Martin Konrad, Jens König, Ulrike Walden, Silke C. Schmidt, Christina J. Huppertz-Kessler, Marcus Weitz, Uwe Querfeld, Peter F. Hoyer, Jörg Dötsch, Markus J. Kemper, Alexandra Balzer, Jan Meis, Burkhard Tönshoff, Lutz T. Weber
Prolonged glucocorticoid therapy is the standard initial treatment for idiopathic nephrotic syndrome in children, but is associated with marked toxic effects. We aimed to assess whether a novel treatment protocol with mycophenolate mofetil is as effective as standard therapy with prednisone, while reducing the burden of glucocorticoid-related side-effects.
长期糖皮质激素治疗是儿童特发性肾病综合征的标准初始治疗,但与明显的毒性作用相关。我们的目的是评估使用霉酚酸酯的新治疗方案是否与强的松标准治疗一样有效,同时减少糖皮质激素相关副作用的负担。
{"title":"Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial","authors":"Marcus R Benz MD, Anja Sander PhD, Rasmus Ehren MD, Prof Britta Höcker MD, Alexander Fichtner MD, Jutta Gellermann MD, Julia Thumfart MD, Brigitte Mayer MD, Katja Sauerstein MD, Anne Mühlig PhD, Raphael Schild MD, Nele Kanzelmeyer MD, Prof Dieter Haffner MD, Henry Fehrenbach MD, Prof Martin Pohl MD, Prof Günter Klaus MD, Silke C Schmidt MD, Prof Martin Konrad MD, Prof Uwe Querfeld MD, Prof Peter F Hoyer MD, Prof Jörg Dötsch MD, Prof Markus J Kemper MD, Alexandra Balzer MSc, Jan Meis PhD, Prof Burkhard Tönshoff MD, Prof Lutz T Weber MD, INTENT investigators, Marcus R. Benz, Anja Sander, Rasmus Ehren, Britta Höcker, Alexander Fichtner, Jutta Gellermann, Julia Thumfart, Norbert Jorch, Brigitte Mayer, Maria Heyde, Matthias Galiano, Katja Sauerstein, Ludwig Patzer, Jun Oh, Anne Mühlig, Raphael Schild, Nele Kanzelmeyer, Dieter Haffner, Henry Fehrenbach, Felix Lechner, Bärbel Lange-Sperandio, Michael van Husen, Martin Pohl, Karsten Häffner, Katalin Dittrich, Stefanie Weber, Günter Klaus, Martin Konrad, Jens König, Ulrike Walden, Silke C. Schmidt, Christina J. Huppertz-Kessler, Marcus Weitz, Uwe Querfeld, Peter F. Hoyer, Jörg Dötsch, Markus J. Kemper, Alexandra Balzer, Jan Meis, Burkhard Tönshoff, Lutz T. Weber","doi":"10.1016/s2352-4642(25)00373-6","DOIUrl":"https://doi.org/10.1016/s2352-4642(25)00373-6","url":null,"abstract":"Prolonged glucocorticoid therapy is the standard initial treatment for idiopathic nephrotic syndrome in children, but is associated with marked toxic effects. We aimed to assess whether a novel treatment protocol with mycophenolate mofetil is as effective as standard therapy with prednisone, while reducing the burden of glucocorticoid-related side-effects.","PeriodicalId":94246,"journal":{"name":"The Lancet. Child & adolescent health","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147465868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Listening to the room 倾听房间
Pub Date : 2026-03-14 DOI: 10.1016/s2352-4642(26)00068-4
Apurva Parikh
{"title":"Listening to the room","authors":"Apurva Parikh","doi":"10.1016/s2352-4642(26)00068-4","DOIUrl":"https://doi.org/10.1016/s2352-4642(26)00068-4","url":null,"abstract":"","PeriodicalId":94246,"journal":{"name":"The Lancet. Child & adolescent health","volume":"127 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147447393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autistic SPACE: clinician advocacy for improving school environments for autistic young people 自闭症空间:临床医生倡导改善自闭症青少年的学校环境
Pub Date : 2026-03-12 DOI: 10.1016/s2352-4642(26)00043-x
Chun-Hao Liu, Mary Doherty, Meng-Chuan Lai
{"title":"Autistic SPACE: clinician advocacy for improving school environments for autistic young people","authors":"Chun-Hao Liu, Mary Doherty, Meng-Chuan Lai","doi":"10.1016/s2352-4642(26)00043-x","DOIUrl":"https://doi.org/10.1016/s2352-4642(26)00043-x","url":null,"abstract":"","PeriodicalId":94246,"journal":{"name":"The Lancet. Child & adolescent health","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147447408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Support without identification: a regressive shift in neurodevelopmental care? 无识别的支持:神经发育护理的退行性转变?
Pub Date : 2026-03-12 DOI: 10.1016/s2352-4642(26)00037-4
Jason Lang, Marion Rutherford, Ruchika Gajwani, Sebastian C K Shaw, Mary Doherty, Helen Minnis
{"title":"Support without identification: a regressive shift in neurodevelopmental care?","authors":"Jason Lang, Marion Rutherford, Ruchika Gajwani, Sebastian C K Shaw, Mary Doherty, Helen Minnis","doi":"10.1016/s2352-4642(26)00037-4","DOIUrl":"https://doi.org/10.1016/s2352-4642(26)00037-4","url":null,"abstract":"","PeriodicalId":94246,"journal":{"name":"The Lancet. Child & adolescent health","volume":"53 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147447402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival, kidney function, and complications in the first year of life following intrauterine shunting for first-trimester fetal megacystis (IUS1st): analysis of a prospective observational cohort 妊娠早期胎儿巨囊炎(IUS1st)宫内分流术后第一年的生存率、肾功能和并发症:一项前瞻性观察队列分析
Pub Date : 2026-03-11 DOI: 10.1016/s2352-4642(26)00011-8
Eva C Weber, Stefan Kohl, Ingo Gottschalk, Florian Recker, Nikolas Neumann, Ina Memetaj-Lang, Thomas M Boemers, Jules Kohaut, Angela Kribs, Lutz Thorsten Weber, Andreas Müller, Brigitte Strizek, Sandra Habbig, Christoph Berg
{"title":"Survival, kidney function, and complications in the first year of life following intrauterine shunting for first-trimester fetal megacystis (IUS1st): analysis of a prospective observational cohort","authors":"Eva C Weber, Stefan Kohl, Ingo Gottschalk, Florian Recker, Nikolas Neumann, Ina Memetaj-Lang, Thomas M Boemers, Jules Kohaut, Angela Kribs, Lutz Thorsten Weber, Andreas Müller, Brigitte Strizek, Sandra Habbig, Christoph Berg","doi":"10.1016/s2352-4642(26)00011-8","DOIUrl":"https://doi.org/10.1016/s2352-4642(26)00011-8","url":null,"abstract":"","PeriodicalId":94246,"journal":{"name":"The Lancet. Child & adolescent health","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147447403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early fetal intervention: balancing technological breakthroughs and long-term morbidity 胎儿早期干预:平衡技术突破与长期发病率
Pub Date : 2026-03-11 DOI: 10.1016/s2352-4642(26)00064-7
Eva Pajkrt
{"title":"Early fetal intervention: balancing technological breakthroughs and long-term morbidity","authors":"Eva Pajkrt","doi":"10.1016/s2352-4642(26)00064-7","DOIUrl":"https://doi.org/10.1016/s2352-4642(26)00064-7","url":null,"abstract":"","PeriodicalId":94246,"journal":{"name":"The Lancet. Child & adolescent health","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral rehydration for severe malnutrition in children with moderate and severe dehydration (GASTROSAM): a phase 2, open-label, superiority randomised controlled trial. 口服补液治疗中度和重度脱水儿童严重营养不良(GASTROSAM):一项2期、开放标签、优势随机对照试验
Pub Date : 2026-03-10 DOI: 10.1016/s2352-4642(25)00371-2
Kathryn Maitland,Hadiza Sainna,Roisin Connon,San Maurice Ouattara,Temmy Sunyoto,Abdullahi Chara,Oluwakemi F Ogundipe,Amadou Saidou Maguina,Mainga Hamaluba,Peter Olupot-Olupot,Florence Alaroker,William Okiror,Denis Aromut,Eric Mwajombo,Emmanuel Oguda,Christabel Mogaka,Céline Langendorf,Juan Emmanuel Dewez,Iza Ciglenecki,Diana M Gibb,Roberta Petrucci,Matthew E Coldiron,Elizabeth C George,
BACKGROUNDInternational guidelines for treatment of children with severe acute malnutrition advise against giving standard oral rehydration solutions (ORS) for dehydration secondary to diarrhoea. Instead, they recommend exclusive use of low-sodium rehydration solution for malnutrition (ReSoMal), due to concerns about both sodium and fluid overload. Supportive evidence is lacking, warranting reappraisal of this guidance. We aimed to assess the safety and superiority of standard WHO-ORS versus ReSoMal.METHODSGASTROSAM was a phase 2, factorial, open-label, superiority randomised controlled trial conducted at six hospitals in four African countries (Kenya, Niger, Nigeria, and Uganda). Children aged 6 months to 12 years with severe acute malnutrition who were admitted to hospital with severe (stratum A) or moderate (stratum B) dehydration and diarrhoea were randomly assigned in a 1:1 ratio to receive ReSoMal or low-osmolarity WHO-ORS. A simultaneous randomisation in stratum A compared two intravenous strategies versus an oral control rehydration strategy (results reported elsewhere). Children with severe dehydration (stratum A) received their allocated ORS as soon as possible. The primary endpoint was change in sodium concentration at 24 h from baseline in all randomised participants and analysed on an intention-to-treat basis. Children with lived experience were not involved in the study design. The trial is registered on the ISRCTN registry (ISRCTN76149273) and the Pan-African Clinical Trials Registry (PACTR202103852542919).FINDINGSBetween Sept 2, 2019, and Oct 27, 2024, 415 eligible children were enrolled (218 [53%] male; 197 [47%] female); 272 were enrolled into stratum A (137 to ReSoMal and 135 to WHO-ORS) and 143 were enrolled into stratum B (69 to ReSoMal and 74 to WHO-ORS). Children were followed up for 28 days; 11 (3%) were lost to follow-up or withdrew. The primary endpoint was assessed in 387 (93%) of 415 participants. The increase in sodium concentration was similar in both groups (5·3 mmol/L [SD 8·1] with ReSoMal vs 5·0 mmol/L [7·6] with WHO-ORS; mean difference for WHO-ORS vs ReSoMal -0·6 [95% CI -1·9 to 0·7], p=0·37). There was no difference in day 28 mortality between the WHO-ORS and ReSoMal groups (19 [9%] vs 24 [12%]; adjusted hazard ratio 0·76 [95% CI 0·41 to 1·41], p=0·39). Fluid overload events (pulmonary oedema and cardiac overload) were actively monitored: none was observed.INTERPRETATIONWHO-ORS resulted in similar outcomes to ReSoMal, and neither strategy led to fluid overload. This finding informs the simplification of guidelines supporting the use of WHO-ORS for the management of dehydration in children regardless of nutritional status.FUNDINGJoint Global Health Trials Scheme of the UK Medical Research Council, UK Department for International Development, Wellcome, and Médecins Sans Frontières.
背景:治疗严重急性营养不良儿童的国际指南建议,对于继发于腹泻的脱水,不要使用标准口服补液。相反,由于担心钠和液体超载,他们建议专门使用低钠补液治疗营养不良(ReSoMal)。缺乏支持性证据,需要重新评估这一指导。我们的目的是评估标准WHO-ORS与ReSoMal的安全性和优越性。方法gastrosam是一项2期、因子、开放标签、优势随机对照试验,在4个非洲国家(肯尼亚、尼日尔、尼日利亚和乌干达)的6家医院进行。因严重(A层)或中度(B层)脱水和腹泻入院的6个月至12岁严重急性营养不良儿童按1:1的比例随机分配接受ReSoMal或低渗透压who - ors。A层的同时随机化比较了两种静脉注射策略与口服对照补液策略(结果在其他地方报道)。严重脱水的儿童(A层)尽快获得分配的补液补液。主要终点是所有随机受试者在24小时内钠浓度较基线的变化,并在意向治疗基础上进行分析。有生活经验的儿童没有参与研究设计。该试验已在ISRCTN注册中心(ISRCTN76149273)和泛非临床试验注册中心(PACTR202103852542919)注册。在2019年9月2日至2024年10月27日期间,415名符合条件的儿童入组(218名[53%]男性,197名[47%]女性);A层272例(ReSoMal组137例,WHO-ORS组135例),B层143例(ReSoMal组69例,WHO-ORS组74例)。随访28天;11例(3%)失去随访或退出。对415名参与者中的387名(93%)进行了主要终点评估。两组患者钠浓度升高相似(ReSoMal组为5.3 mmol/L [SD 8.1], WHO-ORS组为5.0 mmol/L [7.6]; WHO-ORS组与ReSoMal组的平均差异为- 0.6 [95% CI -1·9 ~ 0.7],p= 0.37)。WHO-ORS组与ReSoMal组28天死亡率无差异(19例[9%]vs 24例[12%];校正风险比0.76 [95% CI 0.41 ~ 1.41], p= 0.39)。积极监测液体过载事件(肺水肿和心脏过载):未观察到任何事件。who - ors的结果与ReSoMal相似,两种策略都不会导致体液超载。这一发现有助于简化支持使用世卫组织ors来管理儿童脱水的指南,无论其营养状况如何。资助联合王国医学研究理事会、联合王国国际发展部、惠康基金会和无国界医生组织的联合全球健康试验计划。
{"title":"Oral rehydration for severe malnutrition in children with moderate and severe dehydration (GASTROSAM): a phase 2, open-label, superiority randomised controlled trial.","authors":"Kathryn Maitland,Hadiza Sainna,Roisin Connon,San Maurice Ouattara,Temmy Sunyoto,Abdullahi Chara,Oluwakemi F Ogundipe,Amadou Saidou Maguina,Mainga Hamaluba,Peter Olupot-Olupot,Florence Alaroker,William Okiror,Denis Aromut,Eric Mwajombo,Emmanuel Oguda,Christabel Mogaka,Céline Langendorf,Juan Emmanuel Dewez,Iza Ciglenecki,Diana M Gibb,Roberta Petrucci,Matthew E Coldiron,Elizabeth C George, ","doi":"10.1016/s2352-4642(25)00371-2","DOIUrl":"https://doi.org/10.1016/s2352-4642(25)00371-2","url":null,"abstract":"BACKGROUNDInternational guidelines for treatment of children with severe acute malnutrition advise against giving standard oral rehydration solutions (ORS) for dehydration secondary to diarrhoea. Instead, they recommend exclusive use of low-sodium rehydration solution for malnutrition (ReSoMal), due to concerns about both sodium and fluid overload. Supportive evidence is lacking, warranting reappraisal of this guidance. We aimed to assess the safety and superiority of standard WHO-ORS versus ReSoMal.METHODSGASTROSAM was a phase 2, factorial, open-label, superiority randomised controlled trial conducted at six hospitals in four African countries (Kenya, Niger, Nigeria, and Uganda). Children aged 6 months to 12 years with severe acute malnutrition who were admitted to hospital with severe (stratum A) or moderate (stratum B) dehydration and diarrhoea were randomly assigned in a 1:1 ratio to receive ReSoMal or low-osmolarity WHO-ORS. A simultaneous randomisation in stratum A compared two intravenous strategies versus an oral control rehydration strategy (results reported elsewhere). Children with severe dehydration (stratum A) received their allocated ORS as soon as possible. The primary endpoint was change in sodium concentration at 24 h from baseline in all randomised participants and analysed on an intention-to-treat basis. Children with lived experience were not involved in the study design. The trial is registered on the ISRCTN registry (ISRCTN76149273) and the Pan-African Clinical Trials Registry (PACTR202103852542919).FINDINGSBetween Sept 2, 2019, and Oct 27, 2024, 415 eligible children were enrolled (218 [53%] male; 197 [47%] female); 272 were enrolled into stratum A (137 to ReSoMal and 135 to WHO-ORS) and 143 were enrolled into stratum B (69 to ReSoMal and 74 to WHO-ORS). Children were followed up for 28 days; 11 (3%) were lost to follow-up or withdrew. The primary endpoint was assessed in 387 (93%) of 415 participants. The increase in sodium concentration was similar in both groups (5·3 mmol/L [SD 8·1] with ReSoMal vs 5·0 mmol/L [7·6] with WHO-ORS; mean difference for WHO-ORS vs ReSoMal -0·6 [95% CI -1·9 to 0·7], p=0·37). There was no difference in day 28 mortality between the WHO-ORS and ReSoMal groups (19 [9%] vs 24 [12%]; adjusted hazard ratio 0·76 [95% CI 0·41 to 1·41], p=0·39). Fluid overload events (pulmonary oedema and cardiac overload) were actively monitored: none was observed.INTERPRETATIONWHO-ORS resulted in similar outcomes to ReSoMal, and neither strategy led to fluid overload. This finding informs the simplification of guidelines supporting the use of WHO-ORS for the management of dehydration in children regardless of nutritional status.FUNDINGJoint Global Health Trials Scheme of the UK Medical Research Council, UK Department for International Development, Wellcome, and Médecins Sans Frontières.","PeriodicalId":94246,"journal":{"name":"The Lancet. Child & adolescent health","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147447053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Little kidneys on the global agenda: leveraging the WHO Kidney Health Resolution and World Kidney Day for children. 全球议程上的小肾脏:利用世卫组织肾脏健康决议和世界儿童肾脏日。
Pub Date : 2026-03-02 DOI: 10.1016/s2352-4642(26)00006-4
Randall Lou-Meda,Valerie A Luyckx,Rukshana Shroff
{"title":"Little kidneys on the global agenda: leveraging the WHO Kidney Health Resolution and World Kidney Day for children.","authors":"Randall Lou-Meda,Valerie A Luyckx,Rukshana Shroff","doi":"10.1016/s2352-4642(26)00006-4","DOIUrl":"https://doi.org/10.1016/s2352-4642(26)00006-4","url":null,"abstract":"","PeriodicalId":94246,"journal":{"name":"The Lancet. Child & adolescent health","volume":"53 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147359280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet. Child & adolescent health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1